April 18, 2023

Holland & Knight Health Dose: April 18, 2023

Miranda A. Franco
Holland & Knight Health Dose

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • President Biden Signs Resolution Terminating the COVID-19 National Emergency
  • Senators Introduce Bipartisan Insulin Bill
  • Senate HELP Committee Postpones Drug Pricing Markup
  • House Republicans Question FDA on the Safety of Generic Medications
  • Bipartisan Effort to Address the Physician Fee Schedule
  • CMS Releases FY24 IPPS Proposed Rule
  • CMS Finalizes CY24 Policy Changes for Medicare Advantage and Part D – Prior Authorization Reform Included
  • CMS Releases the FY24 Inpatient Rehabilitation Facility (IRF) Prospective Payment System (PPS) Proposed Rule
  • HIPAA Privacy Enforcement Flexibilities
  • HHS Announces National Cancer Plan to Advance Cancer Moonshot
  • HHS Proposes New Rule on Transparency for Artificial Intelligence

Read the full Health Dose »

Related Insights